search
Back to results

Clinical Study on the Prevention of Surgical Wound Complications for Aneurysmal Thoracic-abdominal Aortic Pathology Using the "PREVENA" System (TVAC)

Primary Purpose

Toraco Abdominal Aneurysm

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Sistema Prevena ™(TVAC)
Standard medication
Sponsored by
IRCCS San Raffaele
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Toraco Abdominal Aneurysm focused on measuring surgical wound, Prevena System

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients over 18 years;
  • patients of any sex, race, age, who have accepted to participate in the study by signing the informed consent form of the study.
  • patients with surgical wounds to treat thoracic-abdominal aortic pathology.

Exclusion Criteria:

  • patients with established sepsis;
  • patients with septic recurrence;
  • patients with sensitivity to silver.

Sites / Locations

  • San Raffaele HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Sistema Prevena ™ (TVAC)

Standard medication

Arm Description

Negative topical pressure system (Sistema Prevena ™).

Standard medication with sterile gauzes and a TNT patch or medicated patch

Outcomes

Primary Outcome Measures

Reduction of surgical site infections
Decrease in the percentage of surgical site infections and / or surgical wound dehiscence within 14 days of surgery

Secondary Outcome Measures

Reduction of adverse events
decrease in the percentage of surgical reoperation
Reduction of adverse events
decrease in the percentage of seromas / hematomas

Full Information

First Posted
April 19, 2018
Last Updated
February 28, 2023
Sponsor
IRCCS San Raffaele
search

1. Study Identification

Unique Protocol Identification Number
NCT03512470
Brief Title
Clinical Study on the Prevention of Surgical Wound Complications for Aneurysmal Thoracic-abdominal Aortic Pathology Using the "PREVENA" System
Acronym
TVAC
Official Title
A Clinical Study, Spontaneous, Randomized and Controlled, on the Prevention of Surgical Wound Complications for Aneurysmal Thoracoabdominal Aortic Disease by Using the "PREVENA ™" Negative Topical Pressure System (TVAC STUDY)
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 24, 2018 (Actual)
Primary Completion Date
September 30, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
IRCCS San Raffaele

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The patients will be randomized into two groups of 100 subjects each one. One arm will be randomized to treatment with a negative topical pressure system (Sistema Prevena ™); while the other arm ("control group") will be randomized to treatment with standard medication with sterile gauzes and a TNT patch or medicated patch as normal traditional medication in use. The medications with a negative topical pressure system (Sistema Prevena ™) will be applied directly in the Operating Room. Thereafter the medication will be checked in the inpatient ward after 48 hours from the intervention, evaluating the possible absorption of exudate on the surface. If no absorption are detected within 48 hours, the medication won't be removed. The medication will be renewed in the 7th day (± 2 days) post-operative; and to follow every 7 (± 2 days) until the points are removed. If the wound continues to progress towards recovery, the protocol will continue until discharge and / or rehabilitation and / or surgery. For each evaluation the photograph of the medication must be taken (which will be deprived of all the identifying elements of the patient).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Toraco Abdominal Aneurysm
Keywords
surgical wound, Prevena System

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Sistema Prevena ™ (TVAC)
Arm Type
Experimental
Arm Description
Negative topical pressure system (Sistema Prevena ™).
Arm Title
Standard medication
Arm Type
Active Comparator
Arm Description
Standard medication with sterile gauzes and a TNT patch or medicated patch
Intervention Type
Device
Intervention Name(s)
Sistema Prevena ™(TVAC)
Intervention Description
The medications with a negative topical pressure system (Sistema Prevena ™) will be applied directly in the Operating Room. Thereafter medication will be checked in the inpatient ward after 48 h from the intervention, evaluating the possible absorption of exudate on the surface. If no absorption are detected within 48 hours, the medication won't be removed and renewed in the 7th day (± 2 days) post-operative; and to follow every 7 (± 2 days) until the points are removed. If the wound continues to progress towards recovery, the protocol will continue until discharge and / or rehabilitation and / or surgery.
Intervention Type
Other
Intervention Name(s)
Standard medication
Intervention Description
standard medication in use (sterile gauze and TNT patch or medicated patches).
Primary Outcome Measure Information:
Title
Reduction of surgical site infections
Description
Decrease in the percentage of surgical site infections and / or surgical wound dehiscence within 14 days of surgery
Time Frame
14 days after surgery
Secondary Outcome Measure Information:
Title
Reduction of adverse events
Description
decrease in the percentage of surgical reoperation
Time Frame
12 month
Title
Reduction of adverse events
Description
decrease in the percentage of seromas / hematomas
Time Frame
12 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients over 18 years; patients of any sex, race, age, who have accepted to participate in the study by signing the informed consent form of the study. patients with surgical wounds to treat thoracic-abdominal aortic pathology. Exclusion Criteria: patients with established sepsis; patients with septic recurrence; patients with sensitivity to silver.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Domenico Baccellieri
Phone
+39022643
Ext
7130
Email
domenico.baccellieri@hsr.it
First Name & Middle Initial & Last Name or Official Title & Degree
Elisa Simonini
Phone
+39022643
Ext
7141
Email
elisa.simonini@hsr.it
Facility Information:
Facility Name
San Raffaele Hospital
City
Milano
ZIP/Postal Code
20132
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Domenico Baccellieri, MD
Phone
+39022643
Ext
7377
Email
domenico.baccellieri@hsr.it
First Name & Middle Initial & Last Name & Degree
Elisa Simonini
Phone
+39022643
Ext
7141
Email
simonini.elisa@hsr.it

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
15695833
Citation
Cutting KF, White RJ. Criteria for identifying wound infection--revisited. Ostomy Wound Manage. 2005 Jan;51(1):28-34.
Results Reference
background
PubMed Identifier
23312938
Citation
Matatov T, Reddy KN, Doucet LD, Zhao CX, Zhang WW. Experience with a new negative pressure incision management system in prevention of groin wound infection in vascular surgery patients. J Vasc Surg. 2013 Mar;57(3):791-5. doi: 10.1016/j.jvs.2012.09.037. Epub 2013 Jan 9.
Results Reference
background

Learn more about this trial

Clinical Study on the Prevention of Surgical Wound Complications for Aneurysmal Thoracic-abdominal Aortic Pathology Using the "PREVENA" System

We'll reach out to this number within 24 hrs